(2-propan-2-yl-1H-pyrrol-3-yl)-[(6S)-2,8,11-triazatricyclo[8.4.0.02,6]tetradeca-1(10),11,13-trien-8-yl]methanone
C19H24N4O — CID 138022195
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2-propan-2-yl-1H-pyrrol-3-yl)-[(6S)-2,8,11-triazatricyclo[8.4.0.02,6]tetradeca-1(10),11,13-trien-8-yl]methanone
(2-propan-2-yl-1H-pyrrol-3-yl)-[(6S)-2,8,11-triazatricyclo[8.4.0.02,6]tetradeca-1(10),11,13-trien-8-yl]methanone (PubChem CID 138022195) has the molecular formula C19H24N4O and a molecular weight of 324.43 g/mol. Its IUPAC name is (2-propan-2-yl-1H-pyrrol-3-yl)-[(6S)-2,8,11-triazatricyclo[8.4.0.02,6]tetradeca-1(10),11,13-trien-8-yl]methanone.
Molecular Properties
| Compound Name | (2-propan-2-yl-1H-pyrrol-3-yl)-[(6S)-2,8,11-triazatricyclo[8.4.0.02,6]tetradeca-1(10),11,13-trien-8-yl]methanone |
|---|---|
| PubChem CID | 138022195 |
| Molecular Formula | C19H24N4O |
| Molecular Weight | 324.43 g/mol |
| Exact Mass | 324.20 |
| IUPAC Name | (2-propan-2-yl-1H-pyrrol-3-yl)-[(6S)-2,8,11-triazatricyclo[8.4.0.02,6]tetradeca-1(10),11,13-trien-8-yl]methanone |
| SMILES | CC(C)c1[nH]ccc1C(=O)N1Cc2ncccc2N2CCC[C@H]2C1 |
| InChI | InChI=1S/C19H24N4O/c1-13(2)18-15(7-9-21-18)19(24)22-11-14-5-4-10-23(14)17-6-3-8-20-16(17)12-22/h3,6-9,13-14,21H,4-5,10-12H2,1-2H3/t14-/m0/s1 |
| InChIKey | WSEJLAHXRRNMMC-AWEZNQCLSA-N |
| XLogP | 3.16 |
| TPSA | 52.23 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 324.43 |
| LogP ≤ 5 | 3.16 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 138022195 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.